Silvert's Disabled Clothing for Elderly Care
Home » Dysport®

Tag Archives: Dysport®

Efficacy and Safety of AbobotulinumtoxinA (Dysport) for the Treatment of Hemiparesis in Adults With Upper Limb … – ScienceDirect.com

Efficacy and Safety of AbobotulinumtoxinA (Dysport) for the Treatment of Hemiparesis in Adults With Upper Limb …  ScienceDirect.com

Read Article Click Here »

Ipsen announces positive results from Phase IIIb/IV ENGAGE study of the combination of Dysport® (abobotulinumtoxinA) with Guided Self-rehabilitation Contracts in adult patients with upper and lower limb spastic hemiparesis – Ipsen

Ipsen announces positive results from Phase IIIb/IV ENGAGE study of the combination of Dysport® (abobotulinumtoxinA) with Guided Self-rehabilitation Contracts in adult patients with upper and lower limb spastic hemiparesis  Ipsen

Read Article Click Here »

Ipsen announces publication in Neurology of results of two studies demonstrating the efficacy and safety of Dysport – Business Wire (press release)

Ipsen announces publication in Neurology of results of two studies demonstrating the efficacy and safety of DysportBusiness Wire (press release)These two studies1 demonstrated the efficacy and safety of Dysport® in adults with hemiparesis who experienced lower limb spasticity. The results showed that, in this population, single Dysport® administration reduced muscle tone, while repeated …and more »

Read Article Click Here »

Ipsen studies show further benefits of Dysport – Zenopa

Ipsen studies show further benefits of DysportZenopaAmong adults with hemiparesis who experienced lower limb spasticity, Dysport was shown to have a positive impact on muscle tone, while repeated administration over a year was well-tolerated and improved both walking speed and the likelihood of …

Read Article Click Here »

Results from Phase 3 of Dysport in Hemiparesis Published in Neurology – Rare Disease Report

Rare Disease Report Results from Phase 3 of Dysport in Hemiparesis Published in NeurologyRare Disease ReportIn the current issue of Neurology, detailed results from a Phase 3 (NCT01249404) and its open-label extension study (NCT01251367) demonstrating the efficacy and safety of Dysport (abobotulinumtoxinA) in adult patients with lower limb spasticity …

Read Article Click Here »